Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOB | P27338 | 9/20 | 0.42 |
| ▸ | MAOA | P21397 | 3/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.38 |
| ▸ | PLA2G2A | P14555 | 4/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | GAA | P10253 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 1/20 | 0.38 |
| ▸ | PKM | P14618 | 1/20 | 0.38 |
| ▸ | PPARG | P37231 | 1/20 | 0.37 |
| ▸ | PPARA | Q07869 | 1/20 | 0.37 |
| ▸ | CCR2 | P41597 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4798109 | 1.00 | MAOB (0.42) | MAOBMAOAKMT2AMCL1PLA2G2A | |
| SCHEMBL4798713 | 0.91 | MAOB (0.43) | MAOBMAOAKMT2AMCL1PLA2G2A | |
| SCHEMBL4798722 | 0.91 | MAOB (0.43) | MAOBMAOAKMT2AMCL1PLA2G2A | |
| SCHEMBL4798983 | 0.81 | MAPT (0.52) | KMT2APLA2G2AALDH1A1GAAMAPT | |
| SCHEMBL4800513 | 0.81 | MAPT (0.52) | KMT2APLA2G2AALDH1A1GAAMAPT | |
| SCHEMBL4799000 | 0.81 | MAPT (0.52) | KMT2APLA2G2AALDH1A1GAAMAPT | |
| SCHEMBL4800748 | 0.73 | ALDH1A1 (0.50) | KMT2APLA2G2AALDH1A1GAAMAPT | |
| SCHEMBL4800762 | 0.73 | ALDH1A1 (0.50) | KMT2APLA2G2AALDH1A1GAAMAPT | |
| SCHEMBL11461356 | 0.73 | PPARD (0.59) | MAOBPLA2G2AALDH1A1GAAMAPT | |
| SCHEMBL7909139 | 0.72 | MAOB (0.56) | MAOBMAOAKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7342039-B2 | Substituted indole oximes | WYETH (US) | 2008-03-11 | — | — | US | disclosed |
| US-20050119326-A1 | Substituted aryloximes | WYETH (US) | 2005-06-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050119326-A1 | Substituted aryloximes | IDO2, TDO2, IDO1 | MAOB 10/4885MAOA 14/4885KMT2A 382/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.